SAPIEN 3 Ultra system | Edwards Lifesciences

Engineered for the future.

Built on the proven SAPIEN platform, the SAPIEN 3 Ultra transcatheter heart valve was designed with patient needs in mind.

SAPIEN 3 Ultra valve

Sealing skirt technology

Now featuring a ~40% taller^*, textured polyethylene terephthalate (PET) outer skirt.

^*Compared to the Edwards SAPIEN 3 valve

Enhanced geometric frame

Short frame height and open cell geometry facilitates coronary access

Valve tissue

Uses same trusted bovine pericardium tissue and process as the SAPIEN 3 valve

Edwards Commander Delivery System:
For predictable, proven results

Features of the Edwards Commander Delivery System

Stable, precise deployment delivering 99% first-time accuracy^†
Low delivery profile
Dual articulation for coaxiality
Optimal positioning control

†The PARTNER II Trial intermediate-risk cohort 30-day unadjusted clinical event rates for TAVR with the SAPIEN 3 valve, AT population (n=1077).

Edwards eSheath Introducer Set:
For controlled deployment

Features of the Edwards eSheath

14F low-profile access leads to significant reduction in major vascular complications
Dynamic Expansion Mechanism (DEM) for low-profile access
Hydrophilic coating designed for ease of insertion

Sign up now to receive event and news information from Edwards Lifesciences including:

Publications
Congress highlights
Webinar invites
Product announcements and updates

For professional use

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable). Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.